日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Pragmatic RCT of FF/UMEC/VI in Patients with Uncontrolled Asthma: PERFORM Protocol

FF/UMEC/VI治疗难治性哮喘患者的实用性随机对照试验:PERFORM方案

Noorduyn, Stephen G; Brown, Nicola; Crawford, Jodie; Demetriou, Lydia; Ismaila, Afisi S; Mbuagbaw, Lawrence; Parpia, Sameer; Sadeghirad, Behnam; Slade, David; Moore, Alison C

Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK

英国慢性阻塞性肺病患者新型单吸入器三联疗法的经济分析

Cai, Rui; Martin, Alan A; Ge, Yuchen; Risebrough, Nancy A; Haeussler, Katrin; Compton, Christopher; Halpin, David M G; Ismaila, Afisi S

Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare Perspective

慢性阻塞性肺疾病单吸入器三联疗法与多吸入器三联疗法的成本效益分析:德国医疗保健视角

Beeh, Kai-Michael; Claussen, Jing; Shah, Dhvani; Martin, Alan; Kendall, Robyn; Dasari, Priyadarsini; Ismaila, Afisi S; Noorduyn, Stephen G

Treatment Discontinuation and Adherence in Patients With Chronic Hepatitis B Infection Newly Initiating Nucleos(t)ide Analogues in Japan: A Retrospective Cohort Study

日本慢性乙型肝炎新发核苷(酸)类似物治疗患者的停药及依从性:一项回顾性队列研究

Kawamatsu, Shinya; Rai, Kiran K; Gielen, Vera; Patel, Amisha; Massey, Olivia; Anderson, Seth W; Handa, Yutaka; Lee, Ethan Yichen; Payne, Poppy; Jimenez, Isabel; Begaj, Kejsi; Salehi, Shayon; Inoue, Jun; Ismaila, Afisi S

Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study

更正:在英格兰慢性阻塞性肺疾病急性加重期患者中及时启动单吸入器氟替卡松糠酸酯、乌美溴铵和维兰特罗(FF/UMEC/VI)治疗的益处:一项回顾性队列研究

Ismaila, Afisi S; Rothnie, Kieran J; Wood, Robert P; Banks, Victoria L; Camidge, Lucinda J; Czira, Alexandrosz; Compton, Chris; Sharma, Raj; Millard, Shannon N; Massey, Olivia; Halpin, David M G

Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians

评估慢性阻塞性肺疾病干预措施的相对效果:面向临床医生的网络荟萃分析教程

Haeussler, Katrin; Ismaila, Afisi S; Malmenäs, Mia; Noorduyn, Stephen G; Green, Nathan; Compton, Chris; Thabane, Lehana; Vogelmeier, Claus F; Halpin, David M G

Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study

在英国真实世界的基层医疗机构中,慢性阻塞性肺疾病患者从多吸入器疗法转换为每日一次单吸入器三联疗法后的疗效:一项回顾性前后队列研究

Rothnie, Kieran J; Wood, Robert P; Czira, Alexandrosz; Banks, Victoria L; Camidge, Lucinda J; Massey, Olivia K I; Seif, Monica; Compton, Chris; Sharma, Raj; Halpin, David M G; Ismaila, Afisi S; Vogelmeier, Claus F

Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany

德国慢性阻塞性肺疾病单吸入器和多吸入器三联疗法用户及新启动者的特征

Beeh, Kai-Michael; Rothnie, Kieran J; Claussen, Jing; Hardtstock, Fränce; Knapp, Rachel K; Wilke, Thomas; Czira, Alexandrosz; Compton, Chris; Ismaila, Afisi S

Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study

慢性阻塞性肺疾病患者三联疗法依从性和持续性评估:一项基于德国医保数据的研究

Vogelmeier, Claus F; Beeh, Kai-Michael; Schultze, Michael; Kossack, Nils; Richter, Lena M; Claussen, Jing; Compton, Chris; Noorduyn, Stephen G; Ismaila, Afisi S; Requena, Gema

Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study

英格兰基层医疗机构中慢性阻塞性肺疾病患者吸入糖皮质激素/长效β2受体激动剂双重疗法的治疗路径、经济负担和临床结局:一项回顾性队列研究

Czira, Alexandrosz; Banks, Victoria; Requena, Gema; Wood, Robert; Tritton, Theo; Wild, Rosie; Compton, Chris; Ismaila, Afisi